Planta Med 2019; 85(18): 1453
DOI: 10.1055/s-0039-3399808
Main Congress Poster
Poster Session 1
© Georg Thieme Verlag KG Stuttgart · New York

Development of lipid-based nanocarriers for increasing gastro-intestinal absorption of lupinifolin extracted from Albizia myriophylla Benth.

N Chudapongse
1   School of Preclinical Sciences, Institute of Science, Suranaree University of Technology,, Nakhon Ratchasima, 30000 Thailand
,
J Musika
1   School of Preclinical Sciences, Institute of Science, Suranaree University of Technology,, Nakhon Ratchasima, 30000 Thailand
› Author Affiliations
Further Information

Publication History

Publication Date:
20 December 2019 (online)

 

Lupinifolin (L), a plant flavonoid, has been reported to possess various pharmacological effects [1]–[3]. It is most likely to exert low oral bioavailability because of poor water solubility [4]. The objective of this study was to develop lipid nanocarriers as drug delivery systems to increase gastro-intestinal absorption of lupinifolin extracted from Albizia myriophylla Benth. Three types of nanocarriers, solid lipid nanoparticles (SLN), nanostructured lipid carriers (NLC), and nanoemulsions (NE) were prepared by emulsification-sonification technique. All three types of nanocarriers loaded with lupinifolin, LSLN, LNLC, and LNE, were successfully synthesized. The lipid components chosen to formulate nanacarriers were Dynasan®116 and/or medium chain triglyceride. Physicochemical characterizations along with releasing profiles of lupinifolin-loaded lipid nanocarriers were compared. It was found that the best lipid nanocarriers for lupinifolin was LNLC, which demonstrated the particle size of 151.5 ± 0.1 nm, monodispersity distribution with PdI of 0.24, negative surface charge at − 41.2 ± 0.7 mV, high encapsulation (99.3%), and high loading capacity (5.0%). The obtained LNLC exhibited prolonged release in simulated circulatory system, but produced low release in gastro-intestinal condition (3.7%). Intestinal permeability of the nanocarriers was further evaluated in everted intestinal sacs method. The results from the ex vivo study indicated that LNLC significantly increased the absorption, compared to native lupinifolin. Lupinifolin absorption through LNLC was about 16 times higher than the native form. In conclusion, lupinifolin-loaded lipid nanocarriers were successfully formulated as delivery systems to enhance its oral bioavailability. Further in vivo experiments are needed to validate the results from this study.

 
  • References

  • 1 Prasad SK, Laloo D, Kumar M. et al. Antidiarrhoeal evaluation of root extract, its bioactive fraction, and lupinifolin isolated from Eriosema chinense . Planta Med 2013; 79: 1620-1627.
  • 2 Sutthivaiyakit S, Thongnak O, Lhinhatrakool T. et al. Cytotoxic and antimycobacterial prenylated flavonoids from the roots of Eriosema chinense . J Nat Prod 2009; 72: 1092-1096.
  • 3 Itoigawa M, Ito C, Ju-ichi M. et al. Cancer chemopreventive activity of flavanones on Epstein-Barr virus activation and two-stage mouse skin carcinogenesis. Cancer Lett 2002; 176: 25-29.
  • 4 Yusook K, Weeranantanapan O, Hua Y. et al. Lupinifolin from Derris reticulata possesses bactericidal activity on Staphylococcus aureus by disrupting bacterial cell membrane. J Nat Med 2017; 71: 357-366.